In a statement released by Atrium Innovations Inc (TSX: ATB), Atrium announced the purchase of Seroyal International, which commercializes premium dietary supplement brands targeting healthcare practitioner channels in Canada and in the U.S. with annualized consolidated revenues of approximately $40 million USD. The transaction closed on December 31, 2010. Atrium is a globally recognized leader in the innovation, formulation, production and commercialization of science-based and professionally endorsed dietary supplements for the health & nutrition industry. Atrium markets a broad portfolio of finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America and Europe. Seroyal was founded in 1984 and distributes three branded families of products (i.e. Genestra, Pharmax and CoreLab), and has distributed the Unda European homeopathic brand since 1990.
